Martin Midstream Partners to Announce 2018 Financial Guidance on February 21
Jan 25, 2018 21:01 pm UTC| Business
KILGORE, Texas, Jan. 25, 2018 -- Martin Midstream Partners (NASDAQ:MMLP) plans to publicly release its 2018 financial guidance on February 21, 2018. Management will discuss annual guidance for 2018 during a conference...
CapStar Financial Holdings, Inc. Announces Fourth Quarter 2017 Results
Jan 25, 2018 21:01 pm UTC| Business
NASHVILLE, Tenn., Jan. 25, 2018 -- CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ:CSTR) reported unaudited net income of $91,000, or $0.01 per share on a fully diluted basis, for the three months...
Marten Transport Announces Fourth Quarter and Year End Results
Jan 25, 2018 21:01 pm UTC| Business
MONDOVI, Wis., Jan. 25, 2018 -- Marten Transport, Ltd. (Nasdaq/GS:MRTN) today reported net income of $65.1 million, or $1.18 per diluted share, for the fourth quarter ended December 31, 2017 – results that include a...
Datawatch Announces First Quarter Fiscal 2018 Financial Results
Jan 25, 2018 21:01 pm UTC| Business
BEDFORD, Mass., Jan. 25, 2018 -- Datawatch Corporation (NASDAQ:DWCH), a leading global provider of self-service data preparation and fast data analytics solutions, today announced that total revenue for its first...
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jan 25, 2018 21:01 pm UTC| Business
SANTA BARBARA, Calif., Jan. 25, 2018 -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on January 19, 2018, the Compensation Committee of the Board of...
Hanmi Financial Corp. to Participate in FIG Partners Bank CEO Forum
Jan 25, 2018 21:01 pm UTC| Business
LOS ANGELES, Jan. 25, 2018 -- Hanmi Financial Corporation (Nasdaq:HAFC) (“Hanmi”), the holding company for Hanmi Bank (the “Bank”), today announced that they will participate in the FIG Partners’ Bank CEO Forum being...
Adverum Biotechnologies and Editas Medicine Extend Research Collaboration
Jan 25, 2018 21:00 pm UTC| Business
MENLO PARK, Calif., Jan. 25, 2018 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced today an extension of...